Graviton BioScience Wins FDA Fast Track for GV101 Therapy
New York, USA, November 3, 2026 Graviton BioScience Corporation has announced that the U.S. Food and Drug Administration (FDA)...
Advertisement
Bridge to Life Wins Canada License, FDA Breakthrough Status
Duluth, Georgia, USA, November 3, 2026 Bridge to Life™ Ltd., a global innovator in organ preservation solutions and perfusion...
Lupin Secures U.S. FDA Approval for Amifampridine 10 mg
Mumbai, India, and Naples, Florida, USA, November 2, 2026 Lupin Limited, a global pharmaceutical company, has announced that it...
Roche Wins FDA Clearance for cobas eplex RP3 Panel
Indianapolis, Indiana, USA, November 2, 2026 Roche Diagnostics has announced that it has received U.S. Food and Drug Administration...
Contrario Medical Wins FDA Clearance for Cyperus Device
Houston, Texas, USA, November 2, 2026 Contrario Medical, Inc. has announced that it has received U.S. Food and Drug...
Neurocrine Launches CAH Education Tools for Healthcare Teams
SAN DIEGO, California, U.S., October 30, 2026 Neurocrine Biosciences, Inc. has announced the launch of two interactive educational resources...
INOVIO Wins FDA Approval for VOCERYQ in RRP Treatment
PLYMOUTH MEETING, Pennsylvania, U.S., October 30, 2026 INOVIO Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration...
Flagship Launches Etcelera to Transform AI Drug Discovery
CAMBRIDGE, Massachusetts, U.S., October 29, 2026 Flagship Pioneering has announced the formation of Etcelera, a biotechnology company designed to...
Eloxx Wins FDA IND Clearance for Exaluren in ADPKD
ARLINGTON, Massachusetts, U.S., October 29, 2026 Eloxx Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA)...
ADC Therapeutics Advances ZYNLONTA Japan Approval Filing
LAUSANNE, Switzerland, October 29, 2026 ADC Therapeutics SA has announced an important regulatory and commercial development for ZYNLONTA® (loncastuximab...
Advertisement
